← FDA DRUG APPROVALS

FDA ANDA · ANDA077433

PAMIDRONATE DISODIUM

Sponsor: AREVA PHARMS

APPLICATION
ANDA077433
TYPE
ANDA
ORIGINAL APPROVAL
2008-11-26
LATEST ACTION
2016-11-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

PAMIDRONATE DISODIUMPrescription
PAMIDRONATE DISODIUM 60MG/VIAL · INJECTABLE · INJECTION
PAMIDRONATE DISODIUMPrescription
PAMIDRONATE DISODIUM 90MG/VIAL · INJECTABLE · INJECTION
PAMIDRONATE DISODIUMPrescription
PAMIDRONATE DISODIUM 30MG/VIAL · INJECTABLE · INJECTION

Approval history

2016-11-29Labeling · Supplement 2AP
2016-11-29Labeling · Supplement 3AP
2008-11-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →